Promising Drugs in Pipeline Debut at Euretina 2017

Pravin U. Dugel, MD, Managing Partner, Retinal Consultants of Arizona; Clinical Professor, USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California; Physician Executive Director, Phoenix Eye Institute, Banner University Medical Center, Phoenix, Arizona describes the promising new drugs coming up the pipeline at the 17th Euretina Congress in Barcelona, Spain. These include next generation drugs for anti-VEGF-A, combination drugs agnostic to anti-VEGF A, and more. Watch the video interview with Dr. Pravin Dugel of Retinal Consultants of Arizona.

Posted in: Uncategorized